| Ytd | 44.81% | |
| 1y | 253.32% |
| Open | 55.29 | Prev Close | 56.58 | Low | 55.29 | High | 56.05 | Mkt Cap | 5.26B |
| Vol | 59.18K | Avg Vol | 2.12M | EPS | -0.22 | P/E | -257.18 | Forward P/E | 77.52 |
| Beta | 1.10 | Short Ratio | 5.25 | Inst. Own | 113.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 50.96 | 200-d Avg | 37.12 | 1yr Est | 58.36 |
TVTX News
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on July 1
HONG KONG, July 8, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced the closing of
Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI's
Guggenheim analyst Vamil Divan maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and raises
Wedbush analyst Laura Chico maintains Travere Therapeutics (NASDAQ:TVTX) with a Outperform and ra
SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced tha
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on June 1
Travere Therapeutics, Inc. (TVTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced lon
HONG KONG, June 4, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced that it has en
Travere Therapeutics, Inc. (TVTX) Discusses Exclusive Licensing and Collaboration Agreement for Sebo
Travere Therapeutics said on Tuesday it has signed a licensing pact with privately held biotech Eve
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that it has entered into an exclusive lic
SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced tha
Expense ratios, yield, and sector breadth set these healthcare ETFs apart-see how their risk profile
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that the Unite
Travere Therapeutics, Inc. (TVTX) Presents at Bank of America Global Healthcare Conference 2026 Tran
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on May 10
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company m
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the pricing of
Dow Jones up 200 points, consumer discretionary shares rise 1.8%, Wells Fargo reports worse-than-exp
Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TV
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that its partner Travere Therapeut
Travere Therapeutics' stock declines as FDA extends review of key kidney drug. Q4 sales forecast
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
During the session on Thursday, 461 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Monday saw 196 companies set new 52-week lows.
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12
Friday's session saw 466 companies set new 52-week highs.